Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Major T-cell responses in multiple sclerosis.

L Steinman1, A Waisman, D Altmann

  • 1Department of Neurologic Sciences, Beckman Center for Molecular and Genetic Medicine, Stanford University, Stanford, CA 94305, USA. lclarry@weizmann.weizmann.ac.il

Molecular Medicine Today
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Downregulation of E-cadherin in pluripotent stem cells triggers partial EMT.

Scientific reports·2021
Same author

Implications of a change in case definition and screening of asylum seekers for hepatitis B surveillance in Germany in 2015 and 2016.

Epidemiology and infection·2020
Same author

Measurement of the <math></math> energy spectrum with IceCube-79: IceCube Collaboration.

The European physical journal. C, Particles and fields·2020
Same author

Evaluation of the German surveillance system for hepatitis B regarding timeliness, data quality, and simplicity, from 2005 to 2014.

Public health·2020
Same author

Cre-lox: Target Sensitivity Matters.

Immunity·2019
Same author

Search for neutrinos from decaying dark matter with IceCube: IceCube Collaboration.

The European physical journal. C, Particles and fields·2019
Same journal

Have tumor cells learnt from microorganisms how to fool the immune system? Escape from immune surveillance of tumors and microorganisms: emerging mechanisms and shared strategies.

Molecular medicine today·2001
Same journal

Molecular signalling in cardiovascular biology: from molecules to man. International symposium organized by the centre for cardiovascular biology and medicine, King's College, London.

Molecular medicine today·2001
Same journal

Is successful gene therapy for retinal disease in sight?

Molecular medicine today·2001
Same journal

New imaging techniques for early diagnosis of Alzheimer's disease.

Molecular medicine today·2001
Same journal

Knocking out NEMO.

Molecular medicine today·2001
Same journal

Clinical gene therapy back in the race.

Molecular medicine today·2001
See all related articles

The immune response in multiple sclerosis (MS) targets a specific myelin basic protein (MBP) region (residues 84-103). Therapies focusing on this immunodominant MBP area may help treat MS.

Area of Science:

  • Neuroimmunology
  • Autoimmune Diseases
  • Demyelinating Diseases

Background:

  • Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
  • The immune system mistakenly attacks myelin, the protective sheath around nerve fibers.
  • Identifying specific targets of the immune response is crucial for understanding MS pathogenesis.

Purpose of the Study:

  • To investigate the T- and B-cell response in multiple sclerosis (MS).
  • To identify the specific region of myelin basic protein (MBP) targeted by the immune system in MS.
  • To explore the potential of targeting this region for MS therapy.

Main Methods:

  • Analysis of T- and B-cell responses in patients with MS and rodent models.
  • Comparison of T-cell receptor gene sequences (VJ and VDJ regions) from MS and experimental autoimmune encephalomyelitis (EAE) lesions.

Related Experiment Videos

  • Immunization studies in rodent models to induce EAE using specific MBP components.

    • Main Results:

    • A significant T- and B-cell response in MS is directed towards myelin basic protein (MBP) residues 84-103.
    • Immunization with this MBP region (MBP84-103) successfully induced experimental autoimmune encephalomyelitis (EAE) in rodent models.
    • T cells in EAE lesions share similarities in VJ and VDJ regions with T cells found in MS lesions and those specific for MBP84-103 from MS patients.

    Conclusions:

    • The immunodominant region of myelin basic protein (MBP) between residues 84 and 103 is a critical target in the immune response of multiple sclerosis (MS).
    • The observed similarities in T-cell receptor sequences suggest a conserved autoimmune response mechanism in MS and EAE.
    • Therapeutic strategies targeting the immune response to MBP84-103 may offer a promising approach for treating multiple sclerosis.